Skip to main content
. 2023 Feb 8;14:1059522. doi: 10.3389/fendo.2023.1059522

Table 4.

Summary of treatment and prognosis of 34 patients.

Parameter Value
Treatment discontinued
continued
dose decreased
na
dextrose intravenously
oral sugar
carbohydrates supplements
glucagon
octreotide
diazoxide
hydrocortisone
diazepam
low-dose re-challenge
27 (79.4%)
2 (5.9%)
3 (8.8%)
2 (5.9%)
30 (88.2%)
2 (5.9%)
1 (2.9%)
4 (11.8%)
1 (2.9%)
1 (2.9%)
1 (2.9%)
1 (2.9%)
2 (5.9%)
Duration of hypoglycemia (26)a rapid
8-24h
24-48h
48-72h
24-47d
1 (3.8%)
10 (38.4%)
7 (26.9%)
6 (23.1%)
2 (7.7%)
Outcome recovery
death
na
30 (88.2%)
3 (8.8%)
1 (2.9%)

na, not applicable.

a Represents the number of patients out of 34 in whom information regarding this particular parameter was provided.